tiprankstipranks
Rein Therapeutics (RNTX)
NASDAQ:RNTX
US Market
RNTX
Rein Therapeutics
RESEARCH TOOLSreports
Want to see RNTX full AI Analyst Report?

Rein Therapeutics (RNTX) Stock News & Sentiment

1,212 Followers
RNTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RNTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
29d ago
RNTX
Rein Therapeutics: Regulatory Overhang Removed and Phase 2 IPF Progress Underscore Best‑in‑Class Potential and Undervalued Upside
Premium
Ratings
Rein Therapeutics: Regulatory Overhang Removed and Phase 2 IPF Progress Underscore Best‑in‑Class Potential and Undervalued Upside
1M ago
RNTX
Rein Therapeutics Completes Private Placement of Notes
Premium
Company Announcements
Rein Therapeutics Completes Private Placement of Notes
2M ago
8K
RNTX
Rein Therapeutics Announces Immediate Board Director Resignation
Premium
Company Announcements
Rein Therapeutics Announces Immediate Board Director Resignation
2M ago
8K
RNTX
Rein Therapeutics Raises Capital via Private Note Offering
Premium
Company Announcements
Rein Therapeutics Raises Capital via Private Note Offering
4M ago
8K
RNTX
Rein Therapeutics Ends Key Financial Agreements
Premium
Company Announcements
Rein Therapeutics Ends Key Financial Agreements
5M ago
8K
RNTX
Rein Therapeutics: Buy Rating Driven by Innovative IPF Treatment and Strong Growth Potential
Premium
Ratings
Rein Therapeutics: Buy Rating Driven by Innovative IPF Treatment and Strong Growth Potential
6M ago
RNTX
More RNTX News >

RNTX News on the Web

KCK LTD. Significantly Reduces Stake in Sight Sciences Inc
GuruFocus News
Neutral
RNTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
TipRanks News
Neutral
Rein Therapeutics past the regulatory uncertainty, says H.C. Wainwright
TipRanks News
Bullish
Rein Therapeutics: Regulatory Overhang Removed and Phase 2 IPF Progress Underscore Best‑in‑Class Potential and Undervalued Upside
TipRanks News
Bullish
Rein Therapeutics (RNTX) Initiates Phase 2 Trial for IPF Treatment
GuruFocus News
Bullish
Rein Therapeutics doses first patient in Phase 2 trial of LTI-03
TipRanks News
Bullish
Rein Therapeutics Completes Private Placement of Notes
TipRanks News
Neutral
Rein Therapeutics Announces Immediate Board Director Resignation
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
RNTX
Sector Average
Media Buzz
Currently, no data available
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RNTX’s Media Buzz Sentiment?
Currently, no data Available
What is RNTX’s weekly average amount of articles?
Currently, no data Available
What is RNTX’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TVTXTravere Therapeutics
HVOOpen Orphan Plc
PBMPsyence Biomedical
QDELQuidelOrtho
Showing the stocks with the most bullish news sentiment over the past week